These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37308363)

  • 1. Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine.
    Ackerson B; Sy LS; Slezak J; Qian L; Reynolds K; Huang R; Solano Z; Towner W; Qiu S; Simmons SR; Jacobsen SJ; Bruxvoort KJ
    Vaccine; 2023 Jul; 41(30):4392-4401. PubMed ID: 37308363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    Bruxvoort K; Slezak J; Qian L; Sy LS; Ackerson B; Reynolds K; Huang R; Solano Z; Towner W; Mercado C; Jacobsen SJ
    JAMA; 2022 Apr; 327(13):1260-1268. PubMed ID: 35333303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Number of Doses With Hepatitis B Vaccine Series Completion in US Adults.
    Bruxvoort K; Slezak J; Huang R; Ackerson B; Sy LS; Qian L; Reynolds K; Towner W; Solano Z; Mercado C; Hyer R; Janssen R; Jacobsen SJ
    JAMA Netw Open; 2020 Nov; 3(11):e2027577. PubMed ID: 33252692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus.
    Wong K; Bruxvoort K; Slezak J; Hsu JY; Reynolds K; Sy LS; Jacobsen SJ
    Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1441-1446. PubMed ID: 34245081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant.
    Champion CR
    Ann Pharmacother; 2021 Jun; 55(6):783-791. PubMed ID: 32988213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV.
    Reilly-Evans B; Dudzik B; Costlow DJ; Hartmann C; Khalsa AM; Kassis C; Zmarlicka MT
    Open Forum Infect Dis; 2023 Jun; 10(6):ofad267. PubMed ID: 37389224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study.
    Girndt M; Plüer M; Dellanna F; Michelsen AK; Beige J; Toussaint K; Wehweck HJ; Koch M; Hafezi Rachti S; Faust J; Bosselmann HP; Witzke O; Janssen RS;
    Hum Vaccin Immunother; 2022 Nov; 18(6):2136912. PubMed ID: 36269938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing Hepatitis B Virus Infection Among U.S. Military Personnel: Potential Impact of a 2-Dose Versus 3-Dose Vaccine on Medical Readiness.
    Oelschlager KA; Termini MS; Stevenson C
    Mil Med; 2023 Jul; 188(7-8):e2067-e2073. PubMed ID: 36525511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
    Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
    Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis.
    Manley HJ; Aweh G; Frament J; Ladik V; Lacson EK
    Nephrol Dial Transplant; 2023 Feb; 38(2):447-454. PubMed ID: 35150277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of HepB-CpG in women with documented pregnancies post-vaccination: A retrospective chart review.
    Kushner T; Huang V; Janssen R
    Vaccine; 2022 May; 40(21):2899-2903. PubMed ID: 35430105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.
    Girndt M; Houser P; Manllo-Karim R; Ervin JE; Charytan C; Chow S; Symonian-Silver M; Lehrner L; Linfert D; Shemin D; Michelsen A; Xie F; Janssen RS
    Vaccine; 2023 May; 41(20):3224-3232. PubMed ID: 37085451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).
    Niu MT; Rhodes P; Salive M; Lively T; Davis DM; Black S; Shinefield H; Chen RT; Ellenberg SS
    J Clin Epidemiol; 1998 Jun; 51(6):503-10. PubMed ID: 9635999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
    Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
    J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination.
    Janssen RS; Bruxvoort K; Jacobsen SJ; Slezak J; David C; Hyer R; Poland GA
    Vaccine; 2021 Sep; 39(39):5666-5672. PubMed ID: 34404556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study.
    Lal H; Poder A; Campora L; Geeraerts B; Oostvogels L; Vanden Abeele C; Heineman TC
    Vaccine; 2018 Jan; 36(1):148-154. PubMed ID: 29174683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.
    Stadtmauer EA; Sullivan KM; El Idrissi M; Salaun B; Alonso Alonso A; Andreadis C; Anttila VJ; Bloor AJ; Broady R; Cellini C; Cuneo A; Dagnew AF; Di Paolo E; Eom H; González-Rodríguez AP; Grigg A; Guenther A; Heineman TC; Jarque I; Kwak JY; Lucchesi A; Oostvogels L; Polo Zarzuela M; Schuind AE; Shea TC; Sinisalo UM; Vural F; Yáñez San Segundo L; Zachée P; Bastidas A
    Hum Vaccin Immunother; 2021 Nov; 17(11):4144-4154. PubMed ID: 34406911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
    Cunningham AL; Lal H; Kovac M; Chlibek R; Hwang SJ; Díez-Domingo J; Godeaux O; Levin MJ; McElhaney JE; Puig-Barberà J; Vanden Abeele C; Vesikari T; Watanabe D; Zahaf T; Ahonen A; Athan E; Barba-Gomez JF; Campora L; de Looze F; Downey HJ; Ghesquiere W; Gorfinkel I; Korhonen T; Leung E; McNeil SA; Oostvogels L; Rombo L; Smetana J; Weckx L; Yeo W; Heineman TC;
    N Engl J Med; 2016 Sep; 375(11):1019-32. PubMed ID: 27626517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
    Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA
    Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.